NFE2L2 and obesity disorder: For instance, it has been shown that Nrf2 pathway activation can repress gluconeogenesis and lipogenesis in liver and prevent fatty liver disease and ameliorate glycemic control in mouse models of obesity and insulin resistance [27,28].